STAT3 and cancer: Of note, differently from NRF2, the activation of STAT3 can promote cell survival/proliferation, either during the first steps of carcinogenesis [23] and in established cancer cells [45–47], also because its activation may be sustained by NF-κB, as in the case of glioblastoma [48].